Olivier Baud Selected Research

Neuroinflammatory Diseases

1/2024	Synergistic effect of sildenafil combined with controlled hypothermia to alleviate microglial activation after neonatal hypoxia-ischemia in rats.
12/2022	The Role of Oxytocin in Abnormal Brain Development: Effect on Glial Cells and Neuroinflammation.
1/2022	[Oxytocin: a new target for neuroprotection?]
1/2021	mGlu3 receptor regulates microglial cell reactivity in neonatal rats.
1/2021	Genetic Deletion of mGlu3 Metabotropic Glutamate Receptors Amplifies Ischemic Brain Damage and Associated Neuroinflammation in Mice.
12/2019	Decreased microglial Wnt/β-catenin signalling drives microglial pro-inflammatory activation in the developing brain.
1/2019	Oxytocin receptor agonist reduces perinatal brain damage by targeting microglia.
1/2019	Neuroinflammation in the Developing Brain: Risk Factors, Involvement of Microglial Cells, and Implication for Early Anesthesia.
1/2018	Modulation of Microglial Activation by Adenosine A2a Receptor in Animal Models of Perinatal Brain Injury.
4/2016	Sildenafil, a cyclic GMP phosphodiesterase inhibitor, induces microglial modulation after focal ischemia in the neonatal mouse brain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Olivier Baud Research Topics

Disease

14	Inflammation (Inflammations) 10/2021 - 01/2011
11	Bronchopulmonary Dysplasia 02/2024 - 02/2009
10	Neuroinflammatory Diseases 01/2024 - 04/2016
10	Ischemia 01/2024 - 01/2011
9	Brain Injuries (Brain Injury) 10/2021 - 10/2004
8	Stroke (Strokes) 09/2018 - 11/2009
6	Cerebral Palsy (Spastic Diplegia) 01/2018 - 10/2004
5	Sepsis (Septicemia) 09/2019 - 02/2011
4	Brain Ischemia (Cerebral Ischemia) 02/2024 - 01/2011
4	Premature Birth (Birth, Premature) 02/2019 - 08/2007
3	Hemorrhage 02/2024 - 01/2021
3	Hypoxia (Hypoxemia) 01/2024 - 10/2008
3	Infarction (Infarctions) 01/2021 - 01/2011
3	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 02/2019 - 10/2013
3	Patent Ductus Arteriosus 01/2019 - 01/2018
2	Necrotizing Enterocolitis 02/2024 - 01/2013
2	Periventricular Leukomalacia (Neonatal Cerebral Leukomalacia) 02/2024 - 10/2004
2	Hypoglycemia (Reactive Hypoglycemia) 01/2023 - 01/2007
2	Fetal Growth Retardation (Intrauterine Growth Retardation) 10/2021 - 12/2015
2	Adrenal Insufficiency (Adrenal Gland Hypofunction) 01/2019 - 01/2019
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 10/2018 - 04/2016
2	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2009 - 06/2006
2	Cysts 06/2006 - 12/2005
2	Necrosis 06/2006 - 12/2005
2	Mitochondrial Diseases (Mitochondrial Disease) 10/2004 - 07/2004
1	Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain) 03/2024
1	Retinopathy of Prematurity (Retrolental Fibroplasia) 02/2024
1	Hypothermia 01/2024
1	Chorioamnionitis 01/2024
1	Enterocolitis 01/2024
1	Amenorrhea 10/2023
1	Wounds and Injuries (Trauma) 10/2023
1	Pulmonary Hypertension 03/2023
1	Hyperglycemia 01/2023
1	Burns 09/2021
1	Intestinal Perforation 01/2021
1	Hemolysis 01/2021
1	Tyrosinemias (Tyrosinemia) 10/2019
1	Propionic Acidemia 10/2019
1	Maple Syrup Urine Disease 10/2019
1	Acute Kidney Injury (Acute Renal Failure) 09/2019
1	Inappropriate ADH Syndrome (SIADH) 09/2019
1	Hyponatremia 09/2019
1	Heart Failure 09/2019
1	Newborn Respiratory Distress Syndrome 02/2019
1	Long Term Adverse Effects 01/2019

Drug/Important Bio-Agent (IBA)

10	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2024 - 04/2016
8	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2023 - 10/2004
6	Neuroprotective AgentsIBA 12/2022 - 12/2005
4	Sildenafil Citrate (Viagra)FDA Link 01/2024 - 03/2014
4	Oxytocin (Pitocin)FDA LinkGeneric 12/2022 - 11/2011
4	N-Methylaspartate (NMDA)IBA 09/2009 - 12/2005
3	SteroidsIBA 10/2023 - 01/2014
3	MelatoninIBA 08/2014 - 09/2009
3	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 09/2009 - 12/2005
3	Kainic Acid Receptors (Kainate Receptor)IBA 09/2009 - 12/2005
2	Proteins (Proteins, Gene)FDA Link 10/2021 - 12/2019
2	Surface-Active Agents (Surfactants)IBA 02/2019 - 10/2013
2	ProstaglandinsIBA 09/2018 - 12/2016
2	CytokinesIBA 01/2018 - 10/2004
2	3-nitrotyrosineIBA 09/2017 - 01/2011
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2017 - 08/2007
2	Oxygen (Dioxygen)IBA 06/2015 - 02/2009
2	AntioxidantsIBA 08/2014 - 01/2011
2	GlucocorticoidsIBA 10/2011 - 08/2007
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2024
1	Dihydrotachysterol (AT 10)IBA 10/2023
1	Hemoglobins (Hemoglobin)IBA 10/2023
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2023
1	TeaIBA 01/2022
1	ProteomeIBA 10/2021
1	metabotropic glutamate receptor 3 (mGluR3)IBA 01/2021
1	SiliconesIBA 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021
1	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 01/2021
1	Mannose (D-Mannose)IBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	Polyurethanes (Polyurethane)IBA 01/2021
1	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 01/2021
1	Phosphates (Orthophosphate)IBA 01/2021
1	Interleukin-4 Receptors (Interleukin 4 Receptor)IBA 01/2021
1	CateninsIBA 12/2019
1	Carnitine-Acylcarnitine Translocase DeficiencyIBA 10/2019
1	MineralocorticoidsIBA 09/2019
1	ProcalcitoninIBA 09/2019
1	ElectrolytesIBA 09/2019
1	Betamethasone (Celestone)FDA Link 02/2019

Therapy/Procedure

8	Therapeutics 02/2024 - 08/2007
4	Injections 01/2021 - 04/2016
4	Protein-Restricted Diet (Diet, Protein Restricted) 01/2021 - 12/2016
3	Ligation 01/2018 - 09/2009
2	Induced Hypothermia 03/2024 - 02/2024
2	Ischemic Postconditioning 10/2015 - 01/2012
1	Lasers (Laser) 02/2024
1	Duration of Therapy 01/2024
1	Laparotomy 10/2023
1	Ostomy 10/2023
1	Sutures (Suture) 10/2023
1	Humidifiers 09/2021
1	Catheters 01/2021